Effective contractile response to voltage-gated NA+ channels revealed by a channel activator

American Journal of Physiology - Cell Physiology

Volumn 304, Issue 8, 2013, Pages

  Vanessa Ho, W S ^a   Davis, Alison J ^a   Chadha, Preet S ^a   Greenwood, Iain A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ca2+ activated Cl channels; Reverse mode of Na+ Ca2+ exchanger; Smooth muscle; Tetrodotoxin; Veratridine

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; MESSENGER RNA; OXIDOPAMINE; PRAZOSIN; RANOLAZINE; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.3; SODIUM CHANNEL NAV1.6; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; SODIUM CHANNEL NAV1.9; TETRODOTOXIN; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENDOTHELIUM; FEMORAL ARTERY; IMMUNOCYTOCHEMISTRY; MALE; MESENTERIC ARTERY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; SYMPATHETIC NERVE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; NAV1.2 VOLTAGE-GATED SODIUM CHANNEL; NAV1.3 VOLTAGE-GATED SODIUM CHANNEL; RATS; RATS, WISTAR; SODIUM CHANNEL BLOCKERS; VASOCONSTRICTION; VERATRIDINE;

RATTUS;

EID: 84878659120     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00164.2012     Document Type: Article

References (40)

1. Allely MC, Brown CM, Kenny BA, Kilpatrick AT, Martin A, Spedding M. Modulation of ai-adrenoceptors in rat left ventricle by ischaemia and acyl camitines: protection by ranolazine. J. Cardiovasc Pharmacol 21: 869-873, 1993.
2. Barnes S, Hille B. Veratridine modifies open sodium channels. J. Gen Physiol 91: 421-443, 1988.
3. + channels are expressed in mesenteric artery smooth muscle cells. Am J Physiol Heart Circ Physiol 289: H137-H145, 2005.
4. Bocquet A, Sablayrolles S, Vacher B, Le Grand B. F 15845, a new blocker of the persistent sodium current, prevents consequences of hyp-oxia in rat femoral artery. Br J Pharmacol 161: 405-415, 2010.
5. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26: 13-25, 2000.
6. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XXXIX Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev 55: 575-578, 2003.
7. Chadha PS, Zunke F, Davis AJ, Jepps TA, Linders JT, Schwake M, Towart R, Greenwood IA. Pharmacological dissection of KV7.1 channels in systemic and pulmonary arteries. Br J Pharmacol 166: 1377-1387, 2012.
8. Davis AJ, Forrest AS, Jepps TA, Valencik ML, Wiwchar M, Singer CA, Sones WR, Greenwood IA, Leblanc N. Expression profile and protein translation of TMEM16A in murine smooth muscle. Am J Physiol Cell Physiol 299: C948-C959, 2010.
9. Davis AJ, Shi J, Pritchard HA, Chadha PS, Leblanc N, Vasilikostas G, Yao Z, Verkman AS, Albert AP, Greenwood IA. Potent vasorelaxant activity of the TMEM16A inhibitor T16Ainh-A01. Br J Pharmacol 168: 773-784, 2013.
10. Favaloro JL, McPherson GA. Vasorelaxation and hyperpolarisation of rat small mesenteric artery by the quaternary anion tetraphenylboron. Naunyn Schmiedebergs Arch Pharmacol 369: 367-373, 2004.
11. Figueroa XF, Chen CC, Campbell KP, Damon DN, Day KH, Ramos S, Duling BR. Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? Am J Physiol Heart Circ Physiol 293: H1371-H1383, 2007.
12. Fort A, Cordaillat M, Thollon C, Salazar G, Mechaly I, Villeneuve N, Vilaine JP, Richard S, Virsolvy A. New insights in the contribution of voltage-gated Nav channels to rat aorta contraction. PLos One 4: e7360, 2009.
13. Fredj S, Sampson KJ, Liu H, Kass RS. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action. Br J Pharmacol 148: 16-24, 2006.
14. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 63: 871-894, 2001.
15. Gyimah P, Ho V. Actions of calcium-sensing receptor ligands in mesenteric, femoral and pulmonary arteries from the rat (Abstract). Proc Br Pharmacol Soc 9: 23, 2011.
16. Ho WS, Randall MD. Endothelium-dependent metabolism by endocan-nabinoid hydrolases and cyclooxygenases limits vasorelaxation to anand-amide and 2-arachidonoylglycerol. Br J Pharmacol 150: 641-651, 2007.
17. Hogestatt ED, Andersson KE. On the postjunctional a-adrenoreceptors in rat cerebral and mesenteric arteries. J. Auton Pharmacol 4: 161-173, 1984.
18. Hölzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43: 143-201, 1991.
19. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 10: 1193-1199, 2004.
20. 2+ exchange in cells expressing NCX1. J Biol Chem 271: 22391-22397, 1996.
21. Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Kräfte DS. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Nail Acad Sei USA 104: 8520-8525, 2007.
22. Jepps TA, Chadha PS, Davis AJ, Harhun ML. Cockerill GW, Olesen SP, Hansen RS, Greenwood IA. Downregulation of KV7.4 channel activity in primary and secondary hypertension. Circulation 124: 602-611, 2011.
23. Lagaud GJ, Stoclet JC, Andriantsitohaina R. Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J Physiol 492: 689-703, 1996.
24. 2+ exchange in rabbit portal vein smooth muscle. Am J Physiol Heart Circ Physiol 268: H1906-H1917, 1995.
25. Lee CH, Ruben PC. Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin. Channels (Austin) 2: 407-412, 2008.
26. Meguro K, Iida H, Takano H, Morita T, Sata M, Nagai R, Nakajima T. Function and role of voltage-gated sodium channel Nav 1.7 expressed in aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 296: H211-H219, 2009.
27. 3H]saxitoxin are associated with voltage-dependent sodium channels in portal vein smooth muscle. Eur J Pharmacol 184: 315-319, 1990.
28. + channel KCNQ genes in human arteries. Br J Pharmacol 162: 42-53, 2011.
29. + channels in cultured human pulmonary artery smooth muscle cells. Pflügers Arch 451: 380-387, 2005.
30. 2+ entry in purinergically stimulated aorta smooth muscle cells. Circ Res 101: 1030-1038, 2007.
31. + current in cultured human coronary myocytes. Circ Res 80: 377-382, 1997.
32. + channels by ranola-zine. Channels (Austin) 2: 449-460, 2008.
33. Ralevic V, Burnstock G. Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins. Br J Pharmacol 117: 1463-1470, 1996.
34. Saleh S, Yeung SY, Prestwich S, Pucovsky V, Greenwood I. Electro-physiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J. Physiol 568: 155-169, 2005.
35. Schmalhofer WA, Calhoun J, Burrows R, Bailey T, Kohler MG, Weinglass AB, Kaczorowski GJ, Garcia ML, Koltzenburg M, Priest BT. ProTx-II, a selective inhibitor of Navl.7 sodium channels, blocks action potential propagation in nociceptors. Mol Pharmacol 74: 1476-1484, 2008.
36. Shiraki H, Kawasaki H, Tezuka S, Nakatsuma A, Kurosaki Y. Endogenous calcitonin gene-related peptide (CGRP) mediates adrenergic-dependent vasodilation induced by nicotine in mesenteric resistance arteries of the rat. Br J Pharmacol 130: 1083-1091, 2000.
37. + channel isoforms by ranolazine. Mol Pharmacol 73: 940-948, 2008.
38. Wang SY, Wang GK. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal 15: 151-159, 2003.
39. White R, Ho WS, Bottrill FE, Ford WR, Hiley CR. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol 134: 921-929, 2001.
40. 2+ channel current and lowers blood pressure. Am J Physiol Heart Circ Physiol 298: H1472-H1483, 2010.